Literature DB >> 28526717

Major contribution of the 3/6/7 class of TRPC channels to myocardial ischemia/reperfusion and cellular hypoxia/reoxygenation injuries.

Xiju He1,2,3, Shoutian Li1,2, Benju Liu1,2, Sebastian Susperreguy4, Karina Formoso4, Jinghong Yao5, Jinsong Kang6, Anbing Shi7, Lutz Birnbaumer8,9, Yanhong Liao10,2,11.   

Abstract

The injury phase after myocardial infarcts occurs during reperfusion and is a consequence of calcium release from internal stores combined with calcium entry, leading to cell death by apoptopic and necrotic processes. The mechanism(s) by which calcium enters cells has(ve) not been identified. Here, we identify canonical transient receptor potential channels (TRPC) 3 and 6 as the cation channels through which most of the damaging calcium enters cells to trigger their death, and we describe mechanisms activated during the injury phase. Working in vitro with H9c2 cardiomyoblasts subjected to 9-h hypoxia followed by 6-h reoxygenation (H/R), and analyzing changes occurring in areas-at-risk (AARs) of murine hearts subjected to a 30-min ischemia followed by 24-h reperfusion (I/R) protocol, we found: (i) that blocking TRPC with SKF96365 significantly ameliorated damage induced by H/R, including development of the mitochondrial permeability transition and proapoptotic changes in Bcl2/BAX ratios; and (ii) that AAR tissues had increased TUNEL+ cells, augmented Bcl2/BAX ratios, and increased p(S240)NFATc3, p(S473)AKT, p(S9)GSK3β, and TRPC3 and -6 proteins, consistent with activation of a positive-feedback loop in which calcium entering through TRPCs activates calcineurin-mediated NFATc3-directed transcription of TRPC genes, leading to more Ca2+ entry. All these changes were markedly reduced in mice lacking TRPC3, -6, and -7. The changes caused by I/R in AAR tissues were matched by those seen after H/R in cardiomyoblasts in all aspects except for p-AKT and p-GSK3β, which were decreased after H/R in cardiomyoblasts instead of increased. TRPC should be promising targets for pharmacologic intervention after cardiac infarcts.

Entities:  

Keywords:  AKT; apoptosis; calcineurin; calcium overload; necrosis

Mesh:

Substances:

Year:  2017        PMID: 28526717      PMCID: PMC5468654          DOI: 10.1073/pnas.1621384114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  70 in total

1.  Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)

Authors:  W E Boden; W H van Gilst; R G Scheldewaert; I R Starkey; M F Carlier; D G Julian; A Whitehead; M E Bertrand; J J Col; O L Pedersen; K I Lie; J P Santoni; K M Fox
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

2.  Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel.

Authors:  Laurent M Dejean; Sonia Martinez-Caballero; Liang Guo; Cynthia Hughes; Oscar Teijido; Thomas Ducret; François Ichas; Stanley J Korsmeyer; Bruno Antonsson; Elizabeth A Jonas; Kathleen W Kinnally
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

3.  Orai1 and STIM reconstitute store-operated calcium channel function.

Authors:  Jonathan Soboloff; Maria A Spassova; Xiang D Tang; Thamara Hewavitharana; Wen Xu; Donald L Gill
Journal:  J Biol Chem       Date:  2006-06-09       Impact factor: 5.157

Review 4.  In vivo TRPC functions in the cardiopulmonary vasculature.

Authors:  Alexander Dietrich; Hermann Kalwa; Beate Fuchs; Friedrich Grimminger; Norbert Weissmann; Thomas Gudermann
Journal:  Cell Calcium       Date:  2007-04-11       Impact factor: 6.817

Review 5.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

6.  trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry.

Authors:  X Zhu; M Jiang; M Peyton; G Boulay; R Hurst; E Stefani; L Birnbaumer
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

7.  Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils.

Authors:  Shyra J Gardai; David A Hildeman; Steve K Frankel; Ben B Whitlock; S Courtney Frasch; Niels Borregaard; Philippa Marrack; Donna L Bratton; Peter M Henson
Journal:  J Biol Chem       Date:  2004-02-06       Impact factor: 5.157

Review 8.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

9.  Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart.

Authors:  Hiroyuki Nakayama; Benjamin J Wilkin; Ilona Bodi; Jeffery D Molkentin
Journal:  FASEB J       Date:  2006-08       Impact factor: 5.191

10.  TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling.

Authors:  Naoyuki Kitajima; Takuro Numaga-Tomita; Masahiko Watanabe; Takuya Kuroda; Akiyuki Nishimura; Kei Miyano; Satoshi Yasuda; Koichiro Kuwahara; Yoji Sato; Tomomi Ide; Lutz Birnbaumer; Hideki Sumimoto; Yasuo Mori; Motohiro Nishida
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

View more
  28 in total

1.  In vitro Models of Ischemia-Reperfusion Injury.

Authors:  Timothy Chen; Gordana Vunjak-Novakovic
Journal:  Regen Eng Transl Med       Date:  2018-05-10

2.  Deletion of diacylglycerol-responsive TRPC genes attenuates diabetic nephropathy by inhibiting activation of the TGFβ1 signaling pathway.

Authors:  Benju Liu; Xiju He; Shoutian Li; Benke Xu; Lutz Birnbaumer; Yanhong Liao
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  Collagen receptor cross-talk determines α-smooth muscle actin-dependent collagen gene expression in angiotensin II-stimulated cardiac fibroblasts.

Authors:  Harikrishnan V; Allen Sam Titus; Randy T Cowling; Shivakumar Kailasam
Journal:  J Biol Chem       Date:  2019-11-07       Impact factor: 5.157

4.  Transient Receptor Potential Canonical 3 and Nuclear Factor of Activated T Cells C3 Signaling Pathway Critically Regulates Myocardial Fibrosis.

Authors:  Youakim Saliba; Victor Jebara; Joelle Hajal; Richard Maroun; Stéphanie Chacar; Viviane Smayra; Joel Abramowitz; Lutz Birnbaumer; Nassim Farès
Journal:  Antioxid Redox Signal       Date:  2018-11-29       Impact factor: 8.401

5.  circDLPAG4/HECTD1 mediates ischaemia/reperfusion injury in endothelial cells via ER stress.

Authors:  Lulu Chen; Wei Luo; Wei Zhang; Han Chu; Jing Wang; Xiaoniu Dai; Yusi Cheng; Tiebing Zhu; Jie Chao
Journal:  RNA Biol       Date:  2019-10-13       Impact factor: 4.652

6.  Osthole attenuates myocardial ischemia/reperfusion injury in rats by inhibiting apoptosis and inflammation.

Authors:  Jingguo Wu; Yang Yang; Nan Xun; Lijin Zeng; Zhenyu Li; Wen Yang; Yanbing Liang; Zhongfu Ma; Hao Tang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 7.  TRPC channels as emerging targets for seizure disorders.

Authors:  Ying Yu; Wei Li; Jianxiong Jiang
Journal:  Trends Pharmacol Sci       Date:  2022-07-12       Impact factor: 17.638

Review 8.  CRAC channels in secretory epithelial cell function and disease.

Authors:  Haiping Liu; Ahmed Kabrah; Malini Ahuja; Shmuel Muallem
Journal:  Cell Calcium       Date:  2018-12-31       Impact factor: 6.817

9.  The Role of TRPC6 in Renal Ischemia/Reperfusion and Cellular Hypoxia/Reoxygenation Injuries.

Authors:  Xin Hou; Mengjun Huang; Xixi Zeng; Yanhong Zhang; Anbang Sun; Qifang Wu; Lin Zhu; Hu Zhao; Yanhong Liao
Journal:  Front Mol Biosci       Date:  2021-07-08

Review 10.  Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials.

Authors:  Yuan-Yuan Gao; Wen Tian; Hui-Nan Zhang; Yang Sun; Jing-Ru Meng; Wei Cao; Xiao-Qiang Li
Journal:  Arch Pharm Res       Date:  2021-03-24       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.